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httpSuccessful treatment of jellyﬁsh sting-induced
severe digital ischemia with intravenous iloprost
infusion
Arthur H. Lo, MBBS, Yiu Che Chan, MBBS, BSc, MD, FRCS, Yuk Law, MBBS, FRCS, and
Stephen W. Cheng, MBBS, MS, FRCS, Hong Kong
Jellyﬁsh sting-induced vasospasm and vasculitis is a rare complication that could lead to severe digital ischemia and
gangrene. We report a 39-year-old woman with severe pain in her right middle, ring, and little ﬁngers after being stung by
a jellyﬁsh. Therapy was initiated with a course of intravenous iloprost infusion and subcutaneous low-molecular-weight
heparin, with successful revascularization. Our case illustrates that although emergency transfer to a vascular center is
ideal, even in a delayed setting, patients can still beneﬁt from specialist vascular care with a combination of medication and
iloprost treatment, with acceptable functional outcome. (J Vasc Surg Cases 2016;2:31-3.)Approximately 70 species of jellyﬁsh are extremely
toxic to humans, with stinging structures (nematocysts)
that are used to sting their prey.1 Contact with a jellyﬁsh
tentacle causes millions of nematocysts to pierce the skin
and inject venom. The venom is a mixture of toxic and
antigenic polypeptides and enzymes. There are three spe-
cies of jellyﬁsh commonly reported to cause fatalities. These
fatal reactions may be caused by anaphylaxis or by the ac-
tion of toxins in the venom on the heart, respiratory center,
or kidneys.2
Other reported complications include cutaneous erup-
tions, motor-sensory neuropathy, vasospasm, and lympho-
cytic vasculitis, which are likely to be caused by the
inﬂammatory mediators or vasoactive substances, such as
bradykinin, histamine, proteases, prostaglandins, and sero-
tonins, which are present in the venom. Toxic proteins ob-
tained from tentacles of certain strains of jellyﬁsh can also
cause platelet aggregation in a concentration-dependent
manner.3 The spectrum of severity of jellyﬁsh sting-
induced vasospasm ranges from Raynaud phenomenon
with cyanosis to ﬁnger necrosis and gangrene requiring
amputation.4 It is worth noting that most of the 9000 spe-
cies of jellyﬁsh are benign, and speciﬁc medical care is not
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://dx.doi.org/10.1016/j.jvsc.2016.02.007We describe a patient who presented with jellyﬁsh
sting-induced digital ischemia and was successfully treated
with intravenous iloprost infusion and subcutaneous low-
molecular-weight heparin. The patient gave written con-
sent for the publication of this report.
CASE REPORT
A 39-year-old right-handed woman with no personal or family
history of rheumatologic or vascular conditions was stung by a
jellyﬁsh on the right arm while swimming in the seas of Penang,
Malaysia. She developed right middle, ring, and little ﬁnger
numbness, and intense pain, together with immediate erythema
and swelling over the right forearm. She ﬂew home the next
day and experienced progressively worsening pain, pallor, coldness,
and numbness over the affected ﬁngers.
She was seen by a dermatologist, who prescribed oral steroids
but with no symptomatic improvement. She was seen in her local
hospital 2 days later when her ﬁngertips became pale and cyanotic.
Emergency duplex imaging and a magnetic resonance angiogram
showed signiﬁcantly reduced ﬂow in the right radial and ulnar
artery distal to the wrist. She was subsequently referred to our
tertiary vascular center for further management.
On presentation to us, the tips of her right middle, ring, and
little ﬁngers were pale and tender, and there was a diffuse erythem-
atous vesiculopapular rash over her anterior forearm (Fig, A). She
complained of coldness and numbness over the dorsal and palmar
side of the affected ﬁngers. There was no motor deﬁcit or swelling,
and she did not have any neurologic deﬁcit in the median or ulnar
nerve function to suggest forearm or hand compartment issues.
The right brachial pulse was normal, but both radial and ulnar
pulses were not palpable at the wrist. Doppler ultrasound imaging
of the right radial and ulnar arteries at the wrist showed monopha-
sic ﬂow suggestive of peripheral digital vasospasm. Our local toxi-
cology center advised that jellyﬁsh sting could induce vascular
insufﬁciency but did not recommend any speciﬁc treatment apart
from keeping the hand warm.
We started our patient on oral aspirin, 1 mg/kg subcutaneous
low-molecular-weight heparin (Clexane; Sanoﬁ Aventis, Surrey,
UK) every 12 hours, and topical glycerine trinitrate patch31
Fig. A, Initially the tips of the patient’s right middle, ring, and little ﬁnger were pale and painful. There was diffuse
erythematous vesiculopapular rash over her anterior forearm that showed progressive improvement after (B) 3 days and
(C) 7 days of iloprost treatment.
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applied to the base of her wrist to promote vasodilatation. However,
her symptoms were nonresolving, and the affected ﬁngers were very
painful and deeply cyanosed.
We decided to start her on a recommended increasing
dosage of intravenous iloprost (Ilomedin20; Bayer Schering
Pharma, Berlin, Germany) with an infusion pump. The infusion
was administered after dilution as an intravenous infusion over
6 hours daily via a peripheral venous catheter with electrocardi-
ography monitoring. The recommended dose of iloprost was
adjusted according to her tolerability within the range of 0.5
to 2.0 ng/kg body weight/min. We diluted 20 mg iloprost in
100 mL normal saline, and with a body weight of 60 kg, she
was given the infusion at 9 mL/h (30 ng/min) over 3 hours
and then at 18 mL/h (60 ng/min) over another 3 hours on
the ﬁrst day. The next day the infusion was started at 18 mL/
h for 3 hours, then at 27 mL/h (90 ng/min) for 3 hours, and
on the third and subsequent days to 36 mL/h (120 ng/min)
for 6 hours. The total cost of medication was wU.S. $1041,
excluding administration cost.
The patient tolerated the infusion well, with no adverse effects
of headache or dizziness. There was gradual and progressive sub-
jective improvement of her symptoms. Clinically, there was better
perfusion of the ﬁngers, and her radial and ulnar pulses were pro-
gressively stronger after 3 days of infusion (Fig, B). The infusion
was continued for 7 days.The patient was discharged with minimal symptoms. Her ﬁn-
gertips had full sensation and were hyperemic (Fig, C). The patient
was happy to be discharged and to return to work. She was dis-
charged on aspirin only. She was last seen 1 week after discharge,
and her right hand had nearly returned to normality.DISCUSSION
This is a report of an adult patient who had severe
jellyﬁsh sting-induced digital vasospasm and was success-
fully treated with iloprost and low-molecular-weight hepa-
rin, thereby preventing debilitating surgery or irreversible
ﬁnger ischemia. Iloprost is a synthetic analogue of epopros-
tenol (prostacyclin [PGI2]; a potent but short-lived prosta-
noid mainly produced in the vascular endothelium), which
has vasodilatory effects and has been used by vascular
surgeons for >20 years for the treatment of patients with
unreconstructable critical leg ischemia, thromboangiitis
obliterans, vasculitis, or severe Raynaud phenomenon.
Apart from a potent but short-lived vasodilatory effect,
iloprost also inhibits platelet aggregation and improves
abnormal vascular reactivity.
Although rare, jellyﬁsh sting-induced severe digital
vasospasm can result in permanent disability if treatment
is delayed. Five cases have been reported worldwide.
Williamson et al5 reported three cases of jellyﬁsh sting in
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limb ischemia and gangrene. Two of the patients under-
went surgical fasciotomy, and surgical exploration was per-
formed on the third patient. Major debilitation occurred in
all three patients. Lam et al6 reported a man who had
ischemia and gangrene of his hand and required fasciotomy
and repeated surgical débridement.
Binnetoglu et al7 reported a boy with bilateral bluish
discoloration of the ﬁngers and areas of necrosis over the
pulps of the index ﬁngers after contact with jellyﬁsh. He
was treated with low-molecular-weight heparin, aspirin,
nifedipine, and sildenaﬁl for 5 days, without clinical
improvement, and was then started on intravenous
iloprost, intravenous steroid, and hyperbaric oxygen. The
iloprost was continued for 4 weeks, and gradually the
necrotic ﬁnger tips autoamputated.7
Major differences in outcomes could be explained by
different toxicity of the jellyﬁsh, although the species
were not usually identiﬁed in real-life situations. In addi-
tion, prompt iloprost infusion in our patient and in the
patient reported by Binnetoglu et al7 also improved the
ﬁnal results.
In a systematic review and meta-analysis of 332 pa-
tients in seven randomized controlled trials comparing
prostaglandin analogues (iloprost or Cisaprost) vs pla-
cebo, Pope et al8 showed beneﬁt in patients with second-
ary Raynaud phenomenon associated with scleroderma,
with evidence for decreasing the severity and frequency
of acute attacks and for preventing or healing digital
ulcers. In most of the studies in the current literature
reviews, the use of iloprost was also shown to be effective
in treating Raynaud phenomenon and, in particular, those
secondary to systemic sclerosis in a multicenter, placebo-
controlled, double-blind study.9 Iloprost can be used
intra-arterially,10 but we have no experience with this
and have only used it intravenously. Even in the Iloprost
in Acute Ischemia of Lower Limbs (ILAILL) Study,
intra-arterial iloprost was followed by a few days of intra-
venous use, so we do not think it would likely be more
cost-effective.10CONCLUSIONS
This is a case of successful treatment of jellyﬁsh
sting-induced digital ischemia with iloprost infusion,
low-molecular-weight heparin, and aspirin. The vasodila-
tory effect of iloprost was apparent by improvement of
symptoms and progressive return of the patient’s radial
and ulnar pulses after 3 days of infusion. Our case illustrated
that although emergent transfer to vascular center is ideal,
even in delayed setting, patients can still beneﬁt from
specialist vascular care with a combination of medication
and iloprost treatment, with acceptable functional outcome.
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